Abstract
Tolbutamide has previously been shown to amplify the pressor effects of “exogenous” catecholamines in conscious dogs, possibly due to sensitization of the α1-adrenoreceptor-mediated vasoconstriction. The objective of this study was to examine if tolbutamide also amplifies the pressor effects of “endogenous” catecholamines released during psychological stress (classical Pavlovian aversive conditioning). Experiments were conducted in β-adrenoreceptor-blocked (propranolol, 1 mg/kg, i.v.) conscious dogs (n=4) trained in classical aversive conditioning. Conditioning was accomplished by following a tone (CS+) with a 1/2 second shock; another tone (CS-) was not followed by any shock and served as control. With saline pretreatment, aversive conditioning (i.e., CS+) increased mean arterial pressure (MAP) only by approximately 4.7% when compared to CS-, whereas with tolbutamide (45 mg/kg, i.v.) pretreatment, the increase in MAP induced by CS+ beyond what was induced by the CS- (approximately 6.2%) was significantly (p<0.05) larger than that with saline pretreatment. In isolated canine femoral arterial segments (n=4), the vasoconstrictor effect of phenylephrine (an α1-agonist) at 5×10−6M (which was the EC50 value) was amplified by 2×10−2M of tolbutamide from 54.0±2.0% to 66.9±2.1%. In conclusion, tolbutamide amplifies the pressor effects of “endogenous” catecholamines in conscious dogs, possibly by sensitization of the α1-adrenoreceptor-mediated vasoconstriction. This mechanism of action is novel and has not been reported with other agents.
Similar content being viewed by others
References
Anderson, D.E., Daley, L.A., Findley, J.D., & Brady, J.V. (1970). A restraint system for the psychophysiological study dogs.Behavior Research Methods and Instruments, 2, 191–194.
Brown, D.R., Randall, D.C., & Raisch, R.M. (1990). A temporally detailed re-analysis of the conditional heart rate response in dogs.Physiology and Behavior, 48, 333–337.
Cohen, D.D., & Randall, D.C. (1984). Classical conditioning of cardiovascular responses.Annual Review in Physiology, 46, 187–197.
Jorgensen, K.D. (1977). The pharmacology of a new hypoglycaemic agent N-[4-(2-2,3-dihydrobenzo(6)furan-7-carboxamide)-ethyl-benzenesulphonyl]-N′-cyclohexylurea (NOVO CS 476). III. General Pharmacology studies.Acta Pharmacology, 40, 234–240.
Keppel, G. (1982). The mixed two-factor design. In G. Keppel (Ed.),Design and analysis: A researcher’s handbook, 2nd ed. (pp. 408–450). Englewood Cliffs, NJ: Prentice-Hall.
Lee, K.C., Wilson, R.A., Randall, D.C., Altiere, R.J., & Kiritsy-Roy, J.A. (1988). An analysis of the haemodynamic effects of tolbutamide in conscious dogs.Clinical and Experimental Pharmacology and Physiology, 15, 379–390.
Author information
Authors and Affiliations
Additional information
Research supported by NIH grant HL19343 to the Department of Physiology and Biophysics, University of Kentucky.
Rights and permissions
About this article
Cite this article
Lee, K.C., Randall, D.C. Potentiation of the pressor response to stress by tolbutamide in dogs. Integrative Physiological and Behavioral Science 28, 22–28 (1993). https://doi.org/10.1007/BF02691197
Issue Date:
DOI: https://doi.org/10.1007/BF02691197